Bayer seeks China approval to expand Kerendia use to non-diabetic chronic kidney disease
Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Short Interest Update
Bayer plans 2027 launch of Bergkamen site-services operating unit
10:32 ETCongestive Heart Failure Market to Register Immense Growth at a CAGR of 8% During the Forecast Period (2026-2036) | DelveInsight
Pantginis Reiterates Buy on ENV-105’s Emerging Resistance-Reversal Profile and Bayer Collaboration; Price Target Maintained at $12
DKSH agrees to buy Bayer’s Meliane oral contraceptive brand in 30 markets